- Open €49.60
- Day Range 49.19 - 50.00
- 52 Week Range 43.20 - 67.66
- Market Cap €55.55B
- Shares Outstanding 1.13B
- Public Float 271.58M
- Beta 0.57
- Rev. per Employee €316.33K
- P/E Ratio 29.95
- EPS €1.67
- Yield 1.70%
- Dividend €0.85
- Ex-Dividend Date Feb 16, 2022
- Short Interest N/A
- % of Float Shorted N/A
- Average Volume 754.46K
Siemens Healthineers AG said Monday that profit and revenue rose in the second quarter on the back of strong demand, and raised its outlook for the full year. The German medical-equipment maker said quarterly net profit ca...
Siemens Healthineers AG said Thursday that it has raised about 2.34 billion euros ($2.76 billion) via an accelerated bookbuilding process, which it plans to use to partially finance the acquisition of Varian Medical System...
Siemens Healthineers AG said Monday its net profit for the first quarter rose on year, and confirmed its previously posted preliminary results, including revenue and outlook. The German medical-equipment maker posted net p...
Siemens Healthineers AG said late Tuesday that earnings and revenue rose for the first quarter and that it has raised its outlook for financial year 2021. The German medical-equipment maker posted adjusted earnings before ...
Siemens Healthineers AG said Tuesday that its net income and revenue for the second quarter of fiscal 2020 increased amid strong growth at its imaging segment and in advanced therapies. The German medical-equipment maker s...
--Siemens trades more than 4% higher as market welcomes power-and-gas spinoff --Move away from fossil-fuel generation to boost valuation, sharpen focus on digital core --Second-quarter profit fell but still beat consensus ...
Siemens AG (SIE.XE) said Wednesday that profit fell in its fiscal second quarter, largely because of a tough comparison with the year-earlier period, but still beat expectations. Net profit dropped to 1.81 billion euros ($...
Siemens Healthineers AG operates as a holding company. The company intends to operate the digital services business. It operates through the following business segments: Imaging, Diagnotics, and Advanced Therapies. The Imaging segment offers diagnostic imaging products and a broad portfolio of advanced imaging and ultrasound systems and solutions. The Diagnostics segment offers products, services and solutions, including a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Advanced Therapies is a supplier of advanced therapy products, services and solutions to the therapy departments of healthcare providers. The company was founded on December 1, 2017 and is headquartered in Erlangen, Germany.